Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 2Pituitary Neoplasms 1Abdominal Cancer 1

Interventions

pasireotide 4Cabergoline 3Surgical Procedures, Operative 2Propofol 2Octreotide 2Human Growth Hormone 2pegvisomant 1entinostat 1corticorelin ovine 1Yoga 1Thyrotropin-Releasing Hormone 1Surveys and Questionnaires 1Supine Position 1Sevoflurane 1Resistance Training 1Radiotherapy 1Radiosurgery 1Photochemotherapy 1Nivolumab 1Neurosurgical Procedures 1Lapatinib 1Ipilimumab 1Ibuprofen 1Hydrocortisone 1Growth Hormone 1Dosage Forms 1Dihematoporphyrin Ether 1Dexamethasone 1Desflurane 1Continuous Glucose Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pituitary Neoplasms × Supine Position × Clear all
NCT04584866 2025-04-29

PosESS

University Hospital, Basel, Switzerland

Phase NA Completed
54 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡